OTCPK:UMHL

Stock Analysis Report

Executive Summary

Umatrin Holding Limited, together with its subsidiaries, sells beauty, personal care, health, and wellness products in Malaysia.

Risk Analysis

Earnings have declined by -17.58% per year over past 5 years

Shares are highly illiquid

Does not have a meaningful market cap ($3M)

Currently unprofitable and not forecast to become profitable over the next 3 years

+ 1 more risk


Snowflake Analysis

Imperfect balance sheet with weak fundamentals.


Similar Companies

Share Price & News

How has Umatrin Holding's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: UMHL's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

5.0%

UMHL

0.6%

US Specialty Retail

1.7%

US Market


1 Year Return

n/a

UMHL

21.3%

US Specialty Retail

23.6%

US Market

Return vs Industry: Insufficient data to determine how UMHL performed against the US Specialty Retail industry.

Return vs Market: Insufficient data to determine how UMHL performed against the US Market.


Shareholder returns

UMHLIndustryMarket
7 Day5.0%0.6%1.7%
30 Day5.0%1.1%3.5%
90 Dayn/a7.5%11.7%
1 Yearn/a23.3%21.3%26.2%23.6%
3 Year-91.6%-91.6%46.9%39.4%53.2%43.3%
5 Yearn/a49.3%36.6%75.5%56.1%

Price Volatility Vs. Market

How volatile is Umatrin Holding's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Umatrin Holding undervalued compared to its fair value and its price relative to the market?


Share Price vs. Fair Value

Below Fair Value: UMHL ($0.02) is trading above our estimate of fair value ($0)

Significantly Below Fair Value: UMHL is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: UMHL is unprofitable, so we can't compare its PE Ratio to the Specialty Retail industry average.

PE vs Market: UMHL is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate UMHL's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: UMHL has negative assets, so we can't compare its PB Ratio to the US Specialty Retail industry average.


Next Steps

Future Growth

How is Umatrin Holding forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

12.4%

Forecasted Retail industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Umatrin Holding has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

  • Take a look at our analysis of UMHL’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access Umatrin Holding's filings and announcements here.
  • Explore growth companies in the Retail industry.

Past Performance

How has Umatrin Holding performed over the past 5 years?

-17.6%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: UMHL is currently unprofitable.

Growing Profit Margin: UMHL is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: UMHL is unprofitable, and losses have increased over the past 5 years at a rate of -17.6% per year.

Accelerating Growth: Unable to compare UMHL's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: UMHL is unprofitable, making it difficult to compare its past year earnings growth to the Specialty Retail industry (4.5%).


Return on Equity

High ROE: UMHL's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Next Steps

Financial Health

How is Umatrin Holding's financial position?


Financial Position Analysis

Short Term Liabilities: UMHL has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: UMHL has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: UMHL has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: UMHL's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet

Inventory Level: UMHL has a high level of physical assets or inventory.

Debt Coverage by Assets: UMHL has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Whilst unprofitable UMHL has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Forecast Cash Runway: UMHL is unprofitable but has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by -65.4% per year.


Next Steps

Dividend

What is Umatrin Holding's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%1.4%markettop25%3.7%industryaverage1.8%forecastin3Yearsn/a

Current dividend yield vs market & industry

Notable Dividend: Unable to evaluate UMHL's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate UMHL's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if UMHL's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if UMHL's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of UMHL's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

What is the CEO of Umatrin Holding's salary, the management and board of directors tenure and is there insider trading?

3.0yrs

Average board tenure


CEO

Warren Eu (40yo)

3yrs

Tenure

US$44,616

Compensation

Mr. Dato Sri Hin Chai Eu, also known as Warren, is a Founder of Umatrin Holding Limited and has been its Chairman, Chief Executive Officer, President and Chief Financial Officer since January 2, 2017 and i ...


Board Age and Tenure

3.0yrs

Average Tenure

40yo

Average Age

Experienced Board: UMHL's board of directors are considered experienced (3 years average tenure).


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Management Team

  • Warren Eu (40yo)

    Founder

    • Tenure: 3yrs
    • Compensation: US$44.62k
  • Bi Teoh (33yo)

    Legal Advisor & Director

    • Tenure: 4.8yrs
    • Compensation: US$29.74k
  • Peter Teng

    Chief Technology Officer

    • William Lee (44yo)

      VP & Director

      • Tenure: 3yrs

    Board Members

    • Warren Eu (40yo)

      Founder

      • Tenure: 3yrs
      • Compensation: US$44.62k
    • Osmanthus Ang (61yo)

      Independent Director

      • Compensation: US$3.72k
    • Bi Teoh (33yo)

      Legal Advisor & Director

      • Tenure: 4.8yrs
      • Compensation: US$29.74k
    • Ling Teng (39yo)

      Director

      • Compensation: US$32.72k
    • William Lee (44yo)

      VP & Director

      • Tenure: 3yrs

    Company Information

    Umatrin Holding Limited's company bio, employee growth, exchange listings and data sources


    Key Information

    • Name: Umatrin Holding Limited
    • Ticker: UMHL
    • Exchange: OTCPK
    • Founded:
    • Industry: Specialty Stores
    • Sector: Retail
    • Market Cap: US$3.065m
    • Shares outstanding: 182.44m
    • Website: https://www.umhl.org

    Number of Employees


    Location

    • Umatrin Holding Limited
    • 315 Madison Avenue
    • 3rd Floor
    • New York City
    • New York
    • 10017
    • United States

    Listings

    TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
    UMHLOTCPK (Pink Sheets LLC)YesCommon StockUSUSDJan 2016

    Biography

    Umatrin Holding Limited, together with its subsidiaries, sells beauty, personal care, health, and wellness products in Malaysia. Its products include hydrogen antioxidant water purifiers; hydrogen alkaline water sticks; Unibersih, a herbal essence that is used for the treatment of constipation, pigmentation, overweight, bad breath, unsound sleep, lack of physical strength, indigestion, abdominal swelling, dry and pale skin, poor immune system, etc.; and Soyme for preventing heart diseases and anti-aging effects, enhancing blood circulation, and reducing the body’s cholesterol levels. The company also offers Sophielicous, an anti-aging supplement to enhance the longevity of skin cells; AKERO SECRET anti-aging skin care series that include moisturizing cleansing foams, facial toners, brightening serums, soothing emulsions, and ageless and protective sunscreen creams; Akero beauty serum to neutralize and repair the effects of emotional and environmental stress on the skin; and Resveratrol, a natural antioxidant to reduce blood viscosity, inhibit platelet aggregation and vasodilation, maintain blood flow, and prevent the occurrence and development of various cardiovascular problems. It markets its products to retail-based end-users and dealers through an online platform; and a retail shop. Umatrin Holding Limited is based in New York City, New York. 


    Company Analysis and Financial Data Status

    All financial data provided by Standard & Poor's Capital IQ.
    DataLast Updated (UTC time)
    Company Analysis2020/01/20 00:10
    End of Day Share Price2020/01/15 00:00
    Earnings2019/09/30
    Annual Earnings2018/12/31


    Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.